Cargando…

Continuous Subcutaneous Insulin Infusion Characteristics in Type 1 Diabetes Children and Adolescents in Qatar

AIM: To describe continuous subcutaneous insulin infusion (CSII) characteristics in type 1 diabetes mellitus (T1DM) children and adolescents using a standardized protocol in routine clinical settings in Qatar. METHODS: A total of 138 T1DM patients (62 males; 76 females; mean age 9.8 ± 3.4 years) wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petrovski, Goran, Al Khalaf, Fawziya, Hussain, Khalid, Campbell, Judith, El Awwa, Ahmed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167275/ https://www.ncbi.nlm.nih.gov/pubmed/30220038 http://dx.doi.org/10.1007/s13300-018-0510-5

Ejemplares similares

The clinical and genetic characteristics of permanent neonatal diabetes (PNDM) in the state of Qatar
por: Al‐Khawaga, Sara, et al.
Publicado: (2019)

Optimizing a Hybrid Closed Loop System in Type 1 Diabetes: A Case Report
por: Petrovski, Goran, et al.
Publicado: (2018)

10-Day structured initiation protocol from multiple daily injection to hybrid closed-loop system in children and adolescents with type 1 diabetes
por: Petrovski, Goran, et al.
Publicado: (2020)

Successful Initiation of Hybrid Closed-Loop System Using Virtual Pump Training Program in a Teenager With Type 1 Diabetes Previously Treated with Multiple Daily Injections
por: Petrovski, Goran, et al.
Publicado: (2020)

Virtual training on advanced hybrid closed‐loop system MiniMed 780G in a teenager with type 1 diabetes previously treated with multiple daily injections: A case report
por: Petrovski, Goran, et al.
Publicado: (2021)

One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes
por: Petrovski, Goran, et al.
Publicado: (2020)

The Epidemiology and Genetic Analysis of Children With Idiopathic Type 1 Diabetes in the State of Qatar
por: Abdel-Karim, Tasneem, et al.
Publicado: (2021)

Glucose control during Ramadan fasting in a teenager with type 1 diabetes on MiniMed 670G hybrid closed-loop system
por: Petrovski, Goran, et al.
Publicado: (2019)

The effect of advanced hybrid closed loop system on glycated hemoglobin (HbA1c) in a young male with type 1 diabetes mellitus and growth hormone treatment: A case report
por: Petrovski, Goran, et al.
Publicado: (2021)

Sib-pair subgroup familial type 1 diabetes mellitus in children in the state of Qatar
por: Afyouni, Houda, et al.
Publicado: (2022)

Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI)
por: Petrovski, Goran, et al.
Publicado: (2022)

Continuous subcutaneous insulin infusion: practical issues
por: Saboo, Banshi D., et al.
Publicado: (2012)

Faster Insulin Aspart for Continuous Subcutaneous Insulin Infusion: Is It Worth It?
por: Rosinha, Patrícia, et al.
Publicado: (2022)

Epidemiology, genetic landscape and classification of childhood diabetes mellitus in the State of Qatar
por: Haris, Basma, et al.
Publicado: (2021)

A Continuous Subcutaneous Insulin Infusion Needle Break
por: George, Minu M., et al.
Publicado: (2015)

Akkermansia, a Possible Microbial Marker for Poor Glycemic Control in Qataris Children Consuming Arabic Diet—A Pilot Study on Pediatric T1DM in Qatar
por: Lakshmanan, Arun Prasath, et al.
Publicado: (2021)

Psychopathology and Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes
por: Rotella, Francesco, et al.
Publicado: (2013)

Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion
por: Ziegler, Ralph, et al.
Publicado: (2021)

Continuous subcutaneous insulin infusion is associated with a reduced rate of microvascular complications
por: Zabeen, Bedowra, et al.
Publicado: (2015)

Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics
por: Pozzilli, Paolo, et al.
Publicado: (2015)

Continuous subcutaneous insulin infusion and flash glucose monitoring in diabetic hemiballism-hemichorea
por: Qiang, Wei, et al.
Publicado: (2020)

Disordered eating behaviour in adolescents with type 1 diabetes on continuous subcutaneous insulin infusion; relation to body image, depression and glycemic control
por: Salah, Nouran Yousef, et al.
Publicado: (2022)

Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes
por: Li, Feng-fei, et al.
Publicado: (2018)

Use of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus: a systematic mapping review
por: Alvarenga, Carolina Spinelli, et al.
Publicado: (2022)

Clinical features, epidemiology, autoantibody status, HLA haplotypes and genetic mechanisms of type 1 diabetes mellitus among children in Qatar
por: Haris, Basma, et al.
Publicado: (2021)

Insulin Pump for Type 2 Diabetes: Use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes
por: Reznik, Yves, et al.
Publicado: (2013)

Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine
por: Hauzenberger, Jasmin R., et al.
Publicado: (2017)

A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes
por: King, Allen B., et al.
Publicado: (2016)

Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin
por: Reid, Laura J., et al.
Publicado: (2021)

Outcomes for continuous subcutaneous insulin infusion users in young adults from lower socioeconomic backgrounds
por: McKee, Alexis M., et al.
Publicado: (2021)

Viral aetiology of bronchiolitis in hospitalised children in Qatar
por: Janahi, Ibrahim, et al.
Publicado: (2017)

Diurnal variation of carbohydrate insulin ratio in adult type 1 diabetic patients treated with continuous subcutaneous insulin infusion
por: Nakamura, Tomoaki, et al.
Publicado: (2014)

A multicentre randomized controlled trial of an empowerment-inspired intervention for adolescents starting continuous subcutaneous insulin infusion - a study protocol
por: Brorsson, Anna Lena, et al.
Publicado: (2013)

Predictors of Continued Breastfeeding at One Year among Women Attending Primary Healthcare Centers in Qatar: A Cross-Sectional Study
por: Nasser, Amal, et al.
Publicado: (2018)

Polymorphic Basal Rates of Continuous Subcutaneous Insulin Infusion among Taiwanese Children with Type 1 Diabetes
por: Lin, Chia-Hung, et al.
Publicado: (2015)

Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes
por: Lyu, Fu-ping, et al.
Publicado: (2020)

Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion
por: Aleppo, Grazia, et al.
Publicado: (2021)

Continuous Subcutaneous Insulin Infusion Therapy Resulting in Improved Glycemic Control in Patient With Low Health Literacy
por: Mandal, Shobha, et al.
Publicado: (2021)

Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear
por: Rini, Christopher James, et al.
Publicado: (2015)

Psychosocial aspects of continuous subcutaneous insulin infusion in children with type 1 diabetes in Egypt; a limited resources country perspective
por: El Samahy, Mona Hussein, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_47vmku2v6n06jsmi41m78gqmba